Merck’s next-gen pneumococcal vaccine scores in phase 3 amid race with Pfizer esagonowsky Mon, 06/22/2020 – 10:49

Mylan, looking to capitalize on Biogen’s Tecfidera patent loss, faces fork in the road on generic launch kblankenship […]

Chronic traumatic encephalopathy (CTE), a neurodegenerative disease caused by repeated head injuries often affecting athletes, can only be […]

Treating a rare type of malignant lung cancer could improve, thanks to near-infrared irradiation and a cancer-targeting compound. […]

By shielding we support the NHSSethina Watson, anaesthetic registrar, North Bristol NHS Trust, says, “Anaesthetists have been on […]

Where did the UK’s covid-19 plan go wrong?1 Politics. Despite repeated assurances that it was “following the science,” […]

A new version of the Code is expected to come into force in July 2021

Study assessing its potential for COVID-19 discontinued due to feasibility of recruitment

The Phase I study is assessing use of a GSK pandemic adjuvant in combination with COVID-19 vaccine candidate […]

Registration will close June 23 but entry forms can be submitted until July 3